{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:13:11Z","timestamp":1763572391228,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.clinthera.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T15:29:38Z","timestamp":1517758178000},"page":"430-439.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009\u20132015"],"prefix":"10.1016","volume":"40","author":[{"given":"Jessica","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila C.","family":"Dollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winnie","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ThuyQuynh","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana M.","family":"Lanzieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.01.006_bib1","series-title":"Viral Infections of Humans","first-page":"805","article-title":"Human herpesviruses: cytomegalovirus","author":"Pass","year":"2014"},{"key":"10.1016\/j.clinthera.2018.01.006_bib2","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.01.006_bib3","series-title":"Infectious Disease of the Fetus and Newborn Infant","first-page":"739","article-title":"Cytomegalovirus","author":"Stagno","year":"2006"},{"key":"10.1016\/j.clinthera.2018.01.006_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/clinids\/20.3.665","article-title":"Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry","volume":"20","author":"Istas","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.01.006_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-3476(94)70327-2","article-title":"Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience","volume":"124","author":"Nigro","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2018.01.006_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J Pediatr"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2018.01.006_bib7","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system","volume":"46","author":"Oliver","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/528376","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease","volume":"197","author":"Kimberlin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.01.006_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.01.006_bib10","series-title":"Red Book: 2012 report of the Committee on Infectious Diseases","first-page":"300","article-title":"Cytomegalovirus infection","year":"2012"},{"key":"10.1016\/j.clinthera.2018.01.006_bib11","series-title":"Red Book: 2015 report of the Committee on Infectious Diseases","first-page":"317","article-title":"Cytomegalovirus infection","year":"2015"},{"key":"10.1016\/j.clinthera.2018.01.006_bib12","unstructured":"Quint JB. Health Research Data for the Real World: The MarketScan Databases. Truven Health Analytics White Paper. https:\/\/marketscan.truvenhealth.com\/marketscanuniversity\/publications\/2015%20MarketScan%20white%20paper.pdf. Accessed February 7, 2017."},{"key":"10.1016\/j.clinthera.2018.01.006_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpeds.2016.05.018","article-title":"The high direct medical costs of Prader-Willi syndrome","volume":"175","author":"Shoffstall","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2018.01.006_bib14","unstructured":"CMS Medicaid. List of Medicaid eligibility groups. https:\/\/www.medicaid.gov\/medicaid-chip-program-information\/by-topics\/waivers\/1115\/downloads\/list-of-eligibility-groups.pdf. Accessed February 6, 2017."},{"key":"10.1016\/j.clinthera.2018.01.006_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/jp.2016.113","article-title":"Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants","volume":"36","author":"McLaurin","year":"2016","journal-title":"J Perinatol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1515\/jpm-2013-0183","article-title":"Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010","volume":"42","author":"Lanzieri","year":"2014","journal-title":"J Perinat Med"},{"key":"10.1016\/j.clinthera.2018.01.006_bib18","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1017\/S0950268815002708","article-title":"Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence","volume":"144","author":"Korndewal","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.clinthera.2018.01.006_bib19","doi-asserted-by":"crossref","first-page":"e20160789","DOI":"10.1542\/peds.2016-0789","article-title":"Outcomes from a hearing-targeted cytomegalovirus screening program","volume":"139","author":"Diener","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2018.01.006_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2015.10.069","article-title":"Symptomatic congenital cytomegalovirus infection is underdiagnosed in British Columbia","volume":"169","author":"Sorichetti","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2018.01.006_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.aje.a115994","article-title":"Completeness of the discharge diagnoses as a measure of birth defects recorded in the hospital birth record","volume":"134","author":"Calle","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/pds.1534","article-title":"Positive predictive value of computerized records for major congenital malformations","volume":"17","author":"Cooper","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2018.01.006_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/bdra.23001","article-title":"Using ICD-9 codes to establish prevalence of malformations in newborn infants","volume":"94","author":"Holmes","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/bdra.23206","article-title":"Validation of congenital anomaly coding in Canada's administrative databases compared with a congenital anomaly registry","volume":"100","author":"Metcalfe","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/pds.3627","article-title":"Validity of maternal and infant outcomes within nationwide Medicaid data","volume":"23","author":"Palmsten","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2018.01.006_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/pds.3740","article-title":"Accuracy of ICD-9-CM coding to identify small for gestational age newborns","volume":"24","author":"Phiri","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2018.01.006_bib27","doi-asserted-by":"crossref","first-page":"F428","DOI":"10.1136\/archdischild-2015-308357","article-title":"Follow-up of infants with congenital cytomegalovirus and normal fetal imaging","volume":"101","author":"Amir","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clinthera.2018.01.006_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0022215108003162","article-title":"Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up","volume":"123","author":"Lackner","year":"2009","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpeds.2017.01.047","article-title":"Newborn dried blood spot polymerase chain reaction to identify infants with congenital cytomegalovirus-associated sensorineural hearing loss","volume":"184","author":"Ross","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2018.01.006_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2018.01.006_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2018.01.006_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0378-3782(12)70003-8","article-title":"Neuroimaging in CMV congenital infected neonates: how and when","volume":"88","author":"Lanari","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.clinthera.2018.01.006_bib34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/jp.2017.41","article-title":"Long-term outcomes of children with symptomatic congenital cytomegalovirus disease","author":"Lanzieri","year":"2017","journal-title":"J Perinatol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib35","first-page":"703","article-title":"Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations","volume":"15","author":"Barkovich","year":"1994","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clinthera.2018.01.006_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.braindev.2013.04.001","article-title":"Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection","volume":"36","author":"Capretti","year":"2014","journal-title":"Brain Dev"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818300080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818300080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:01Z","timestamp":1758963001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818300080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0149291818300080"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.01.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009\u20132015","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}